Havana, Cuba, Mar 8.- The amino acid P-28 is a drug in clinical trials whose results in cancer therapy are encouraging, said Dr. Ananda Chakrabarty, a professor at the University of Illinois, Chicago, USA.
Speaking to Prensa Latina, Chakrabarty said that the administration of medication to patients with certain types of neoplasm, melanoma, sarcoma and colon cancer or prostate cancer in advanced stages of the disease, caused tumor remission.
Chakrabarty explained that the medication is based on a peptide derived from a protein, and is designed to kill cancer cells. Toxicity tests conducted in U.S. patients have been negative so far, the expert added.
Chakrabarty, the first scientist who patented a living organism, a bacterium capable of degrading oil, participates in Biotechnology Conference Havana-2012, where he gave two lectures.
Several symposia on the biology of cancer, hepatitis and autoimmune diseases are also taking place at the event, where Cuban experts present some of the work developed in Cuba on these themes.
Based at the Havana International Conference Center until March 8, the forum is attended by some 600 specialists from 41 nations, said Gerardo Guillen, vice president of the organizing committee.
During the conference, organized by the Centre for Genetic Engineering and Biotechnology (ICGEB), research and clinical trials for vaccines for HIV / AIDS and dengue have been presented. (Prensa Latina)